Showing results (351-360 of 3,013) with videos related to
Sort By:
Pageof 302
Cardiovascular Drugs and Therapy|October 30, 1998
Metabolic supplementation with orotic acid and magnesium orotateF L RosenfeldtCardiovascular Drugs and Therapy|October 30, 1998
Significance of the 5-phosphoribosyl-1-pyrophosphate pool for cardiac purine and pyrimidine nucleotide synthesis: studies with ribose, adenine, inosine, and orotic acid in ratsH G ZimmerCardiovascular Drugs and Therapy|October 30, 1998
On the significance of magnesium in extreme physical stressS W Golf, S Bender, J GrüttnerCardiovascular Drugs and Therapy|March 1, 1997
Systemic and regional hemodynamic effects of gallopamil in patients with essential hypertensionR G Ketelhut, F H Messerli, C Losem, et al.Cardiovascular Drugs and Therapy|March 1, 1997
Ambulatory blood pressure monitoring in patients with essential hypertension treated with a new calcium antagonist, cilnidipineM Tominaga, Y Ohya, A Tsukashima, et al.Cardiovascular Drugs and Therapy|April 1, 1997
Emerging class III antiarrhythmic agents: mechanism of action and proarrhythmic potentialL A Nair, A O GrantCardiovascular Drugs and Therapy|April 1, 1997
Activity of Procanbid, procainamide twice-daily formulation, to suppress ventricular premature depolarizations. The Study Group InvestigatorsN Z Kerin, W L Meengs, G C Timmis, et al.Cardiovascular Drugs and Therapy|January 1, 1997
Clinical efficacy of propantheline bromide in neurocardiogenic syncope: pharmacodynamic implicationsJ C Yu, R J SungCardiovascular Drugs and Therapy|January 1, 1997
Alternatives to mega-trials in cardiovascular diseaseJ R HamptonCardiovascular Drugs and Therapy|January 1, 1997
Controversies in preconditioningJ W de Jong, R de Jonge, A Marchesani, et al.Pageof 302